In addition, the sphingosine-1-phosphate inhibitor FTY720 [52] reduces colitis-associated colorectal tumour growth via indirect downregulation of STAT3 and activation of NF-κβ signalling [53]. Here, STAT3 is linked to colorectal neoplasm.